NK
Nilesh Khushalchand Doshi
About Nilesh Khushalchand Doshi
Data last updated:
Nilesh Khushalchand Doshi is a Director at Eurosoft Pharma Private Limited (since 2021), Director at Riki International Private Limited (since 2021) and Director at Qualichem Specialties Private Limited (since 2008). The companies operate in Pharma, Financial Services and Business Outsourcing. The 2 current companies with reported revenue have a combined latest revenue of ₹2.41 Cr; the largest is Eurosoft Pharma Private Limited at ₹2.37 Cr (FY 2024). Earlier, Nilesh Khushalchand Doshi was a Director at Natext Biotech Private Limited (2005–2013) and Additional Director at Tenshi Ksm Private Limited (2019–2020) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Eurosoft Pharma Private Limited U24230MH1995PTC087378 | Director | 09 Nov 2021 | 1995 | ₹2.37 Cr (FY 2024) | Active |
| Riki International Private Limited U80903MH1999PTC121198 | Director | 09 Nov 2021 | 1999 | ₹4.5 Lakh (FY 2025) | Active |
| Qualichem Specialties Private Limited U24231TZ2008PTC014912 | Director | 08 Dec 2008 | 2008 | Under Process Of Striking Off |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Natext Biotech Private Limited U24234MH2005PTC156487 | Director | 03 Nov 2005 | 2005 | Strike Off | |
 Tenshi Ksm Private Limited U24299KA2019PTC121725 | Additional Director | 05 Jun 2019 | 2019 | ₹17.6 Lakh (FY 2021) | Dissolved Under Section 59(8) |
| Eurosoft Impex Private Limited U51900MH2000PTC126966 | Director | 02 Jun 2000 | 2000 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Nilesh Khushalchand Doshi
| Name | DIN | Company | Designation |
|---|---|---|---|
| Paresh Kothari Chandrakant | 00565355 | Eurosoft Pharma Private Limited | Director |
| Rikin Doshi Nilesh | 01426354 | Eurosoft Pharma Private Limited , Riki International Private Limited | Director |
| Rupal Ashok Jhaveri | 09387768 | Eurosoft Pharma Private Limited | Director |
| Pallavi Nilesh Doshi | 00936821 | Riki International Private Limited | Director |
| Shridhara Kela | 02592314 | Qualichem Specialties Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nilesh Khushalchand Doshi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nilesh Khushalchand Doshi
Nilesh Khushalchand Doshi currently holds 3 directorships: Eurosoft Pharma Private Limited (Director, since 09 Nov 2021, revenue ₹2.37 Cr (FY 2024)); Riki International Private Limited (Director, since 09 Nov 2021, revenue ₹4.5 Lakh (FY 2025)); Qualichem Specialties Private Limited (Director, since 08 Dec 2008).
Nilesh Khushalchand Doshi was first appointed on 02 Jun 2000 as Director at Eurosoft Impex Private Limited. The most recent appointment on record is 09 Nov 2021 at Riki International Private Limited.
The 2 current companies of Nilesh Khushalchand Doshi that report revenue have a combined latest revenue of ₹2.41 Cr: Eurosoft Pharma Private Limited ₹2.37 Cr (FY 2024); Riki International Private Limited ₹4.5 Lakh (FY 2025).
Nilesh Khushalchand Doshi held 3 earlier board appointments: Natext Biotech Private Limited (Director, 03 Nov 2005 to 01 Aug 2013); Tenshi Ksm Private Limited (Additional Director, 05 Jun 2019 to 19 Oct 2020); Eurosoft Impex Private Limited (Director, from 02 Jun 2000).
The current boards of Nilesh Khushalchand Doshi's companies include Paresh Kothari Chandrakant (Eurosoft Pharma Private Limited), Rikin Doshi Nilesh (Eurosoft Pharma Private Limited), Rupal Ashok Jhaveri (Eurosoft Pharma Private Limited), Pallavi Nilesh Doshi (Riki International Private Limited), Shridhara Kela (Qualichem Specialties Private Limited).